Article

Mechanisms Behind Metabolic Switches in Cells Discovered

Identifying cancer cells’ metabolic states could improve treatments.

In a recent study, researchers uncovered the mechanisms behind the metabolic switch observed in irregular cells.

A change in cellular energy metabolism can cause normal cells to change into cells with an abnormal metabolic state, according to a study published by Nature Scientific Reports. Cancer cells switch from creating energy through aerobic respiration to glycolysis, which is the same metabolic switch seen in yeast cells.

In the study, researchers looked at how yeast cells create energy to analyze different metabolic oscillations behind the switch.

“Due to the thermodynamic openness of a living cell, the inability to instantaneously match fluctuating supply and demand in energy metabolism results in nonautonomous time-varying oscillatory dynamics,” said researcher Aneta Stefanovska, PhD.

Researchers were able to show changes in metabolic state were due to alterations in the ability of the oscillator to resist external perturbations, they wrote.

The researchers believe that their findings could be used to identify metabolic switching in cells, in particular cancer cells.

“Focusing on the transitions between metabolic states could facilitate the development of new therapeutic strategies,” concluded researcher Gemma Lancaster, PhD.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Image Credit: © Krakenimages.com - stock.adobe.com